News zum Sektor Gesundheit aus Island

 

Announcement no. 21/2026 13 April 2026 Reykjavik, Iceland/Copenhagen, Denmark, 13 April 2026. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 61/2025 dated 23 December 2025. During the period 7 April  to 10 April 2026 Embla Medical has acquired 60,000 shares under the Program at the average price of DKK 27.18. Following the transactions below, the Company holds 858,442 shares, corresponding to 0.20% of the Company'...

Announcement no. 20/2026 7 April 2026 Reykjavik, Iceland/Copenhagen, Denmark, 7 April 2026. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 61/2025 dated 23 December 2025. During the period 30 March to 1 April 2026 Embla Medical has acquired 35,000 shares under the Program at the average price of DKK 26.35. Following the transactions below, the Company holds 798,442 shares, corresponding to 0.19% of the Company's...

Announcement no. 19/2026 30 March 2026 Reykjavik, Iceland/Copenhagen, Denmark, 30 March 2026. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 61/2025 dated 23 December 2025. During the period 23 March to 27 March 2026 Embla Medical has acquired 61,000 shares under the Program at the average price of DKK 26.44. Following the transactions below, the Company holds 763,442 shares, corresponding to 0.18% of the Company'...

Announcement no. 18/2026 23 March 2026 Reykjavik, Iceland/Copenhagen, Denmark, 23 March 2026. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 61/2025 dated 23 December 2025. During the period 16 March to 20 March 2026 Embla Medical has acquired 50,000 shares under the Program at the average price of DKK 27.64. Following the transactions below, the Company holds 702,442 shares, corresponding to 0.16% of the Company'...

Announcement no. 17/2026 16 March 2026 Reykjavik, Iceland/Copenhagen, Denmark, 16 March 2026. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 61/2025 dated 23 December 2025. During the period 9 March to 13 March 2026 Embla Medical has acquired 50,000 shares under the Program at the average price of DKK 29.34. Following the transactions below, the Company holds 652,442 shares, corresponding to 0.15% of the Company'...

Announcement no. 16/2026 13 March 2026 Reference is made to announcement no. 15/2026 published on 10 March 2026 (Embla Medical: Results of the Annual General Meeting 2026). Reykjavik, Iceland/Copenhagen, Denmark, March 13, 2026. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced that the capital reduction of ISK 2,441,257 nominal value was registered with the Icelandic Register of Enterprises today. 2,441,257 of the Company's own shares with a nominal value of ISK 1 each were cancelled. The share capital of Embla...

Announcement no. 15/2026 10 March 2026 Reykjavik, Iceland/Copenhagen, Denmark, 10 March, 2026. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced the results from the 2026 Annual General Meeting. Results of the Annual General Meeting · The meeting approved to carry the Company's net profit in 2025 over to the following year. · The meeting approved the Company's Consolidated Financial Statements for the year 2025. · The meeting approved the Company's Remuneration Policy. See attachment. · The meeting...

Announcement no. 14/2026 9 March 2026 Reykjavik, Iceland/Copenhagen, Denmark, 9 March 2026. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 61/2025 dated 23 December 2025. During the period 2 March to 6 March 2026 Embla Medical has acquired 48,000 shares under the Program at the average price of DKK 30.02. Following the transactions below, the Company holds 3,043,699 shares, corresponding to 0.71% of the Company's...

Announcement no. 13/2026 5 March 2026 Reykjavik, Iceland/Copenhagen, Denmark, March 5, 2026. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced details on the candidates to the Board of Directors of Embla Medical hf., to be elected at the Company's 2026 Annual General Meeting. The Annual General Meeting will take place Tuesday 10 March 2026 at 9:00 AM (GMT) at Embla Medical's headquarters at Grjótháls 1-3, Reykjavík, Iceland. Details on the candidates can be found enclosed to this announcement. Further...

Announcement no. 12/2026 3 March 2026 Reykjavik, Iceland/Copenhagen, Denmark, 3 March 2026. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 61/2025 dated 23 December 2025. During the period 23 February to 27 February 2026 Embla Medical has acquired 45,711 shares under the Program at the average price of DKK 29.96. Following the transactions below, the Company holds 2,995,699 shares, corresponding to 0.70% of the...

Announcement no. 11/2026 24 February 2026 Reykjavik, Iceland/Copenhagen, Denmark, February 24, 2026. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced the final agenda and proposals for the Company's 2026 Annual General Meeting, which will be held on Tuesday 10 March 2026 at 9:00 AM (GMT) at the Company's headquarters at Grjótháls 1-5, Reykjavík, Iceland. The final agenda can be found enclosed with this announcement. No changes have been made to the previously announced agenda and proposals. Further information...

Announcement no. 10/2026 23 February 2026 Reykjavik, Iceland/Copenhagen, Denmark, 23 February 2026. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 61/2025 dated 23 December 2025. During the period 16 February to 20 February 2026 Embla Medical has acquired 28,883 shares under the Program at the average price of DKK 30.16. Following the transactions below, the Company holds 2,949,988 shares, corresponding to 0.69%...

Announcement no. 9/2026 17 February 2026 Reykjavik, Iceland/Copenhagen, Denmark, February 17, 2026. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced that Embla Medical's Annual General Meeting will be held on Tuesday 10 March 2026 at 9:00 AM (GMT) at the Company's headquarters at Grjótháls 1-5, Reykjavík, Iceland. The convocation can be found enclosed to this announcement and includes the proposed agenda for the Annual General Meeting and information on shareholders' participation and registration, shareholders'...

Announcement no. 8/2026 16 February 2026 Reykjavik, Iceland/Copenhagen, Denmark, 16 February 2026. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 61/2025 dated 23 December 2025. During the period 9 February to 13 February 2026 Embla Medical has acquired 25,486 shares under the Program at the average price of DKK 30.89. Following the transactions below, the Company holds 2,921,105 shares, corresponding to 0.68% of...

Announcement no. 7/2026 9 February 2026 Reykjavik, Iceland/Copenhagen, Denmark, 9 February 2026. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 61/2025 dated 23 December 2025. During the period 2 February to 6 February 2026 Embla Medical has acquired 43,000 shares under the Program at the average price of DKK 31.31. Following the transactions below, the Company holds 2,895,619 shares, corresponding to 0.67% of...

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

COPENHAGEN, Denmark, Feb. 3, 2026 /PRNewswire/ -- Announcement no. 5/2026 Interim Report Q4 and Full Year 2025 Sveinn Sölvason, President and CEO, comments: "We delivered solid sales in the fourth quarter amounting to USD 257 million. Organic sales growth was 7% and 10% in local currency......

Announcement no. 6/2026 3 February 2025 Embla Medical hf: 2025 Annual Report The full Annual report including Remuneration and Governance Reports can be downloaded from our website https://emblamedical.com/investor-relations/annual-report Letter from our President and CEO Sveinn Sölvason 2025 was a year of meaningful progress for Embla Medical. Across geographies and patient care settings, the need for our solutions remains as strong as ever, and once again, our teams delivered with focus and purpose.  We achieved 6% organic growth driven by strong performance in...

Announcement no. 5/2026 Interim Report Q4 and Full Year 2025 Sveinn Sölvason, President and CEO, comments: “We delivered solid sales in the fourth quarter amounting to USD 257 million. Organic sales growth was 7% and 10% in local currency including contribution from the majority investment in Streifeneder ortho.production, which was completed in September 2025. Growth in the quarter was driven by Prosthetics & Neuro Orthotics, supported by continued strong growth momentum in EMEA and recently launched innovation. Sales in Patient Care picked up in Q4 with a strong finish to the...

Announcement no. 4/2026 2 February 2026 Reykjavik, Iceland/Copenhagen, Denmark, 2 February 2026. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 61/2025 dated 23 December 2025. During the period 26 January to 30 January 2026 Embla Medical has acquired 30,584 shares under the Program at the average price of DKK 31.78. Following the transactions below, the Company holds 2,852,619 shares, corresponding to 0.66% of...